How we work

We constantly push ourselves in the pursuit of better – better solutions, better processes and better ways of working that help our clients navigate complexity and make better decisions with greater confidence

The Journey

We recognise that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

The Journey

Our Values

Our culture is founded on a strong set of values that guide how we work with each other and our clients. We are a PASSIONATE team who believe in COLLABORATIVE SPIRIT and a CAN-DO attitude. We build BOLD solutions and make insightful recommendations because we dig deeper and remain CONSTANTLY CURIOUS, to provide positive challenge and FRESH THINKING

Our Values

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

Job openings

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of Biotechs globally from our offices in the US and Europe

Our locations

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our People

Expert Navigation

Explore case studies that bring to life how we’ve uncovered hidden insights, explored scientific options and helped make difficult strategic choices

Case studies
How pharmaceutical companies are driving positive social change
How pharmaceutical companies are driving positive social change
Sustainability and corporate social responsibility (CSR) strategies have shown huge success across industries. The benefits include attracting customers (a 2015 Nielsen survey showed 66% people will pay more for sustainable brands, up from 55% in 2014 and 50% in 2013); attracting and retaining employees; reducing business costs by improving process and supply chain efficiency; and distinguishing your company above competition.
Will a new label extension help Merck realize a rare antimicrobial success story, and what does this mean for the fight against AMR?
Will a new label extension help Merck realize a rare antimicrobial success story, and what does this mean for the fight against AMR?
In rare, positive news in the field of antibiotics, Merck recently announced the approval of Zerbaxa to combat two types of pneumonia commonly found in hospitals.
Are digital diagnostics the way forward in the battered field of Alzheimer's?
Are digital diagnostics the way forward in the battered field of Alzheimer's?
Alzheimer's continues to be a major and steadily growing problem for healthcare systems, with an estimated 5 million patients affected by the disease in the US alone.
From Systematic Literature Reviews to Indirect Treatment Comparisons – Where Do We Start and How Do We Succeed?
From Systematic Literature Reviews to Indirect Treatment Comparisons – Where Do We Start and How Do We Succeed?
This article in ISMPPs May newsletter got me thinking about the way we evaluate literature. If we agree that there is a need to redefine the importance and focus of systematic literature reviews, don’t we also need to reevaluate the literature at the top of the evidence pyramid? I agree that not all evidence is created equally, but surely we should be putting a greater emphasis on patients' experience/voice when focussing on payers and regulators as the target audience.